A New Breed Of Accelerators Helps Drive Digital Health
This article was originally published in Start Up
Many digital health start-ups require more than just capital to navigate the complicated waters of the health care industry, and a new group of seed accelerators has emerged to help meet their needs. An interview with Healthbox director Ateet Adhikari.
You may also be interested in...
In a long-awaited final guidance, FDA affirmed its plan to practice enforcement discretion for most mobile medical apps, except those applications that present the same risks as conventional FDA-regulated devices. Some digital health stakeholders praised the guidance, while others wished FDA has waited.
A new, mobile monitoring technology has entered the cardiovascular market, and companies that already own a piece of the landscape are paying close attention to its debut. Start-up AliveCor Inc. has launched a heart rhythm monitor that works with smartphones – one of the first of a new breed of mobile medical devices that could have a disruptive impact on health care as it is performed today.
A new Medicare cost-control program aimed at reducing costly hospital readmissions has heart failure squarely in the cross-hairs, and the consequences could mean hundreds of thousands of dollars in lost Medicare revenue for hospitals that fail to meet the new readmission standards. As a result, providers are scrambling to implement programs to assess and reduce heart failure readmissions, and a growing number of device companies are touting a variety of technologies they believe could help them achieve that goal.